Biosimilar Immune Checkpoint Mabs
It was not long after the discovery of immune checkpoints (IC) that it was shown that cancer cells evolve to express more inhibitory immune checkpoint molecules to help them evade the immune system. However, ICs also give oncologists an opportunity to treat cancer in the same way: by either blocking the inhibitory molecules or by […]
Biosimilar Immune Checkpoint Mabs Read More »